\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationBarcelona
Leitat, one of Spain's technology centres, Acció, the Catalan Agency for Business Competitiveness, and the Provincial Council of Barcelona bring together cities, start-ups, companies, universities and technology centres for 2 days of inspiring keynote talks, panel discussions, and networking opportunities through our Innovation Marketplace and targeted matchmaking for the upcoming City Mission and city-related CL5 Horizon Europe calls.
This on-site event organised with the support of the Enterprise Europe Network (EEN), the largest business support network worldwide.
Main topics are Buildings/built environment, Circular urban economy, Energy, Mobility, Zero pollution.
More information and registration: here
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
